Insight Molecular Diagnostics Inc. (IMDX)
Last updated: 2026-11-17 21:47:40. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
Summary
Insight Molecular Diagnostics Inc. (IMDX) operates in the IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES sector and is listed on NASDAQ. The stock is currently priced at $1.77, with a market capitalization of $70.03M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.49 to $7.56. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$70.03M | |
$1.68 | |
$1.81 | |
$1.49 | |
$1.86 | |
1.20M | |
218.48K | |
-- | |
$7.56 | |
$1.49 | |
-- | |
-- |
Insight Molecular Diagnostics Inc. (IMDX) After-Hours Stock Price
Insight Molecular Diagnostics Inc. (IMDX) is trading at $1.77 in after-hours trading as of 2026-11-17 21:43:00, down 0.34% ($0.01) from the regular-session close of $1.77.
After-hours trading shows how investors are pricing IMDX after the regular session closes. The current after-hours price is near the regular-session close, indicating cautious after-hours sentiment.
Why Is IMDX Stock Up Today?
IMDX is up 1.42% in after-hours trading.
Insight Molecular Diagnostics shares are trading lower after the company reported Q3 financial results. Also, the company announced a proposed public offering.
Insight Molecular Diagnostics Inc. (IMDX) 7-Day Stock Price Change
Over the past seven days, Insight Molecular Diagnostics Inc. (IMDX) moved from $2.49 to $1.77, representing a decline of 28.80% ($0.72).
The stock traded between $1.49 and $2.72 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 129.11 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
IMDX 52-Week Price Position
Position in Range: 4.7%
IMDX is currently trading at $1.77, placing it 4.7% of the way from its 52-week low of $1.49 to its 52-week high of $7.56. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Insight Molecular Diagnostics Inc. (IMDX)?
Insight Molecular Diagnostics Inc is a pioneering diagnostics technology company whose mission is to democratize access to novel molecular diagnostic testing to improve patient outcomes. The Company's flagship technology quantifies a molecular biomarker known as donor-derived cell-free DNA (dd-cfDNA). It is also in the process of rebranding its RUO test kit, GraftAssure, as GraftAssureIQ, and rebranding its future in-vitro diagnostic (IVD) test kit as GraftAssureDx. The company geographically operates in the United States, the United Kingdom, Europe, and the Asia-Pacific regions, with maximum revenue generated from the USA.
Insight Molecular Diagnostics Inc. Information
| Industry | IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES |
| Employees | 58 |
| Exchange | NASDAQ |
| Company Website |
IMDX News
Latest news related to Insight Molecular Diagnostics Inc. and IMDX stock.
- Read Full Article
- Read Full Article
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Aytu BioPharma (NASDAQ:AYTU) shares rose 45.0% to $2.64 during Tuesday's pre-market session. The market value of their outstanding shares is at $19.7 million. The company's, Q1 earnings came out
- Read Full Article
iMDx Says GraftAssureDx FDA Review Progressing; Preparing Response To FDA Request For Additional Information
- Read Full Article
Insight Molecular Diagnostics Announces Proposed Public Offering; No Size Disclosed
Ways to Trade IMDX at MEXC
How to Buy Insight Molecular Diagnostics Inc. (IMDX) Stock on MEXC
Eligible investors can buy real shares of Insight Molecular Diagnostics Inc. (IMDX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Insight Molecular Diagnostics Inc. (IMDX) stock price today?
2.Is IMDX stock going up or down today?
3.What is IMDX pre-market price?
4.What is IMDX after-hours price?
5.Is IMDX stock trading now?
6.Where does IMDX sit relative to its 52-week high and low?
7.What sector is Insight Molecular Diagnostics Inc. in?
8.What is Insight Molecular Diagnostics Inc.'s market capitalization and where is it listed?
9.How is IMDX valued in terms of P/E ratio and EPS?
10.Does Insight Molecular Diagnostics Inc. pay a dividend?
Explore More US Stocks
Compliance Disclosure and Data Source
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to IMDX, including Stocks, Tokenized Stocks, and Stock Futures.
Disclaimer
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Search Stocks
IMDX Stock Calculator
Estimate the value between IMDX shares and USD.
IMDX Shares to USD
1.00 IMDX shares = 1.773 USD
Calculations are estimates based on the latest available price and are for reference only.


